Amlodipine Benzoate Patent Expiration

Amlodipine Benzoate is Used for managing hypertension and angina. It was first introduced by Azurity Pharmaceuticals Inc in its drug Katerzia on Jul 8, 2019. 2 different companies have introduced drugs containing Amlodipine Benzoate.


Amlodipine Benzoate Patents

Given below is the list of patents protecting Amlodipine Benzoate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Katerzia US10799453 Amlodipine formulations Apr 11, 2039 Azurity
Katerzia US10695329 Amlodipine formulations Oct 16, 2037 Azurity
Katerzia US10894039 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US10952998 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US10959991 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11364230 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11471409 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11484498 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11701326 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US11918685 Amlodipine formulations Oct 06, 2037 Azurity
Katerzia US12053461 Amlodipine formulations Oct 06, 2037 Azurity



Amlodipine Benzoate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amlodipine Benzoate Generic API Manufacturers

Only one generic application has been filed for Amlodipine Benzoate.

Given below is the list of companies who have filed for Amlodipine Benzoate generic, along with the locations of their manufacturing plants worldwide.


1. AMNEAL

Amneal Pharmaceuticals Llc has filed for 1 generic for Amlodipine Benzoate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE/ML

suspension Discontinued ORAL N/A Jun 13, 2023


Manufacturing Plant Locations
New

Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.

Country City Firm Name
United States
Piscataway Amneal Pharmaceuticals, LLC
Branchburg Amneal Pharmaceuticals, LLC
Paterson Amneal Pharmaceuticals, Llc
East Hanover Amneal Pharmaceuticals LLC
Brookhaven Amneal Pharmaceuticals of New York, LLC
Hauppauge Amneal Pharmaceuticals of New York, LLC
Glasgow Amneal Pharmaceuticals LLC
Bridgewater Amneal Complex Products Research LLC
India
Ahmedabad Amneal Pharmaceuticals Private Ltd.
Matoda Amneal Pharmaceuticals Private Ltd.
Tal Bavla, Ahmedabad Amneal Pharmaceuticals Pvt. Ltd.
Hyderabad Amneal Oncology Private Limited